Q4 2014 Holdings
Filed 2015-02-17 | 121 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $650.3M | 20,481,442 | 52.6% |
| Biomarin Pharmaceuticals(BMRN) | COM | 09061G101 | $335.7M | 3,713,950 | 27.1% |
| Biocryst Pharmaceuticals Inc.(BCRX) | COM | 09058V103 | $130.3M | 10,713,686 | 10.5% |
| Cerus(CERS) | COM | 157085101 | $73.0M | 11,702,727 | 5.9% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $19.9M | 6,715,462 | 1.6% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $18.3M | 163,393 | 1.5% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $1.1M | 11,600 | 0.1% |
| Pharmacyclics Inc. | COM | 716933106 | $1.1M | 9,129,231 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $1.1M | 14,845,559 | 0.1% |
| Synageva Biopharma Corp. | COM | 87159A103 | $989.2K | 10,660,432 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $895.2K | 27,861,720 | 0.1% |
| Avanir Pharmaceuticals | COM | 05348P401 | $652.8K | 38,513,713 | 0.1% |
| Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | $542.7K | $219,440,000 | 0.0% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $436.6K | 13,656,318 | 0.0% |
| Incyte Corporation Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | $421.6K | $274,500,000 | 0.0% |
| Incyte Corporation Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | $388.0K | $259,000,000 | 0.0% |
| Incyte Corporation Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAJ1 | $336.2K | $40,446,000 | 0.0% |
| Anacor Pharmaceuticals | COM | 032420101 | $135.6K | 4,204,702 | 0.0% |
| Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $102.1K | $22,898,000 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $98.7K | 4,283,732 | 0.0% |
| Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $89.0K | $21,500,000 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $86.6K | 6,157,789 | 0.0% |
| Salix Pharmaceuticals | COM | 795435106 | $73.0K | 635,321 | 0.0% |
| Acorda Therapeutics Notes 1.75% 6/15/2021 | CONV BONDS | 00484MAA4 | $69.8K | $60,900,000 | 0.0% |
| Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $67.3K | $34,720,000 | 0.0% |
| Vanda Pharmaceuticals, Inc.(VNDA) | COM | 921659108 | $64.0K | 4,472,153 | 0.0% |
| Xoma Corp. | COM | 98419J107 | $60.8K | 16,924,013 | 0.0% |
| Xenoport | COM | 98411C100 | $60.5K | 6,903,628 | 0.0% |
| Versartis Inc. | COM | 92529L102 | $51.2K | 2,281,744 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $44.1K | 2,380,074 | 0.0% |
| DBV Technologies Inc. | SPONSORED ADR | 23306J101 | $41.2K | 1,519,229 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $33.6K | 4,449,797 | 0.0% |
| Derma Sciences | COM | 249827502 | $32.9K | 3,537,137 | 0.0% |
| TG Therapeutics(TGTX) | COM | 88322Q108 | $32.5K | 2,050,313 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $30.9K | 755,534 | 0.0% |
| Salix 1.5% 3/15/19 | CONV BONDS | 795435AE6 | $27.3K | $15,000,000 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $26.8K | 2,776,143 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $26.2K | 2,607,784 | 0.0% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $24.1K | 256,108 | 0.0% |
| Repros Therapeutics | COM | 76028H209 | $19.9K | 2,000,000 | 0.0% |
| Insmed Inc.(INSM) | COM | 457669307 | $17.1K | 1,107,850 | 0.0% |
| Omeros Corp.(OMER) | COM | 682143102 | $16.1K | 648,101 | 0.0% |
| Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | $14.7K | $12,500,000 | 0.0% |
| Sangamo Biosciences, Inc.(SGMO) | COM | 800677106 | $14.5K | 955,332 | 0.0% |
| Bluebird Bio Inc. | COM | 09609G100 | $13.8K | 150,000 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $12.4K | 554,590 | 0.0% |
| Clovis Oncology(CLVSEUR) | COM | 189464100 | $11.3K | 202,630 | 0.0% |
| Macrogenics, Inc.(MGNX) | COM | 556099109 | $10.9K | 311,891 | 0.0% |
| Kythera Biopharmaceuticals | COM | 501570105 | $9.9K | 286,255 | 0.0% |
| Xencor(XNCR) | COM | 98401F105 | $9.5K | 591,371 | 0.0% |